Patents by Inventor Ki Cheul SOHN
Ki Cheul SOHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11065294Abstract: Provided is a composition for enhancing effects of an anticancer agent using an oriental medicine, jaeumganghwa-tang, bojungikgi-tang, or yukmijihwang-tang. More particularly, provided is a composition for treating a neoplastic disease by administering an anticancer agent into an individual, and administering an oriental medicine into the individual within 30 minutes. The composition remarkably reduces side effects occurring when the anticancer agent is administered alone by co-administration of the oriental medicine, reduces cytotoxicity, and has higher anticancer activity than that when the anticancer agent is administered alone.Type: GrantFiled: May 15, 2014Date of Patent: July 20, 2021Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Joon Seok Byun, Sae Kwang Ku, Ki Cheul Sohn, Seung Mo Kim, Chang Hyeong Lee, Dae Sung Hyun, Jong Dae Kim, Sung Hwan Park, Min A. Kwak
-
Patent number: 10765647Abstract: Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.Type: GrantFiled: May 3, 2018Date of Patent: September 8, 2020Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Seok Bong Kang, Ho Sang Sohn, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
-
Patent number: 10695394Abstract: The present invention relates to a composition containing a Pinelliae Rhizoma and Scutellariae Radix extract as an active ingredient to reduce side effects caused by an anticancer drug, and more particularly, a composition for reducing side effects such as damage to the gastrointestinal tract and a gastrointestinal motility disorder by administering an anticancer drug. The composition of the present invention has an excellent effect of reducing side effects in administration of the anticancer drug through an antioxidative function, and synthesis, secretion and control of the functions of gastrin and serotonin producing gastrointestinal endocrine cells.Type: GrantFiled: April 26, 2018Date of Patent: June 30, 2020Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Heon Mo Ryu, Dae Jun Kim, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
-
Patent number: 10342835Abstract: The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.Type: GrantFiled: May 2, 2018Date of Patent: July 9, 2019Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Chang Hyeong Lee, Sang Gyung Kim, Im Hee Shin, Seung Mo Kim, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
-
Patent number: 10286040Abstract: The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.Type: GrantFiled: December 26, 2017Date of Patent: May 14, 2019Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Chang Hyeong Lee, Sang Gyung Kim, Im Hee Shin, Seung Mo Kim, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
-
Publication number: 20190060384Abstract: The present invention relates to a composition for the treatment or prevention of lung cancer, including gefitinib and a Lonicera japonica extract, and more particularly, the present invention has an advantage in that it is possible to remarkably increase the therapeutic effects of gefitinib on lung cancer and simultaneously prevent and reduce side effects caused by various treatments of lung cancer, and the like by administering gefitinib to an individual and administering a Lonicera japonica extract to the individual.Type: ApplicationFiled: August 20, 2018Publication date: February 28, 2019Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Sang Hoon Joo, Young Joon Lee, Sae-Kwang Ku, Joon-Seok Byun, Ki Cheul Sohn
-
Publication number: 20190046477Abstract: Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.Type: ApplicationFiled: May 3, 2018Publication date: February 14, 2019Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Seok Bong Kang, Ho Sang Sohn, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
-
Publication number: 20180289763Abstract: The present invention relates to a composition containing a Pinelliae Rhizoma and Scutellariae Radix extract as an active ingredient to reduce side effects caused by an anticancer drug, and more particularly, a composition for reducing side effects such as damage to the gastrointestinal tract and a gastrointestinal motility disorder by administering an anticancer drug. The composition of the present invention has an excellent effect of reducing side effects in administration of the anticancer drug through an antioxidative function, and synthesis, secretion and control of the functions of gastrin and serotonin producing gastrointestinal endocrine cells.Type: ApplicationFiled: April 26, 2018Publication date: October 11, 2018Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Heon Mo RYU, Dae Jun KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
-
Publication number: 20180243358Abstract: The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.Type: ApplicationFiled: May 2, 2018Publication date: August 30, 2018Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
-
Publication number: 20180185447Abstract: The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.Type: ApplicationFiled: December 26, 2017Publication date: July 5, 2018Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
-
Publication number: 20160184382Abstract: Provided is a composition for enhancing effects of an anticancer agent using an oriental medicine, jaeumganghwa-tang, bojungikgi-tang, or yukmijihwang-tang. More particularly, provided is a composition for treating a neoplastic disease by administering an anticancer agent into an individual, and administering an oriental medicine into the individual within 30 minutes. The composition remarkably reduces side effects occurring when the anticancer agent is administered alone by co-administration of the oriental medicine, reduces cytotoxicity, and has higher anticancer activity than that when the anticancer agent is administered alone.Type: ApplicationFiled: May 15, 2014Publication date: June 30, 2016Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Joon Seok BYUN, Sae Kwang KU, Ki Cheul SOHN, Seung Mo KIM, Chang Hyeong LEE, Dae Sung HYUN, Jong Dae Kim, Sung Hwan PARK, Min A. KWAK
-
Publication number: 20160184243Abstract: Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.Type: ApplicationFiled: May 2, 2014Publication date: June 30, 2016Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Seok Bong KANG, Ho Sang SOHN, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
-
Publication number: 20160113988Abstract: The present invention relates to a composition containing a Pinelliae Rhizoma and Scutellariae Radix extract as an active ingredient to reduce side effects caused by an anticancer drug, and more particularly, a composition for reducing side effects such as damage to the gastrointestinal tract and a gastrointestinal motility disorder by administering an anticancer drug. The composition of the present invention has an excellent effect of reducing side effects in administration of the anticancer drug through an antioxidative function, and synthesis, secretion and control of the functions of gastrin and serotonin producing gastrointestinal endocrine cells.Type: ApplicationFiled: May 21, 2014Publication date: April 28, 2016Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Heon Mo RYU, Dae Jun KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
-
Publication number: 20160101156Abstract: The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stern cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stern cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.Type: ApplicationFiled: May 1, 2014Publication date: April 14, 2016Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
-
Publication number: 20160058810Abstract: The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.Type: ApplicationFiled: May 1, 2014Publication date: March 3, 2016Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTEInventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU